Polymeric drug delivery systems for localized cancer chemotherapy

Drug Delivery

Volumn 17, Issue 6, 2010, Pages 365-375

  De Souza, Raquel ^a   Zahedi, Payam ^a   Allen, Christine J ^a   Piquette Miller, Micheline ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biodegradable and biocompatible; Cancer; Localized delivery systems; Natural polymers; Synthetic polymers

Indexed keywords

ALBUMIN; ALGINIC ACID; ANTINEOPLASTIC AGENT; BUSERELIN; CAMPTOTHECIN; CAPECITABINE; CARMUSTINE; CHITOSAN; CISPLATIN; COLLAGEN; CYTARABINE; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; ERLOTINIB; GEFITINIB; GELATIN; GOSERELIN; HYALURONIC ACID; IMATINIB; IMYOCET; LEUPRORELIN; OCTREOTIDE; ONCOGEL; PACLITAXEL; POLYANHYDRIDE; POLYESTER; POLYMER; POLYSACCHARIDE; TRIPTORELIN; UNCLASSIFIED DRUG; BIOPOLYMER; DRUG CARRIER;

BIOCOMPATIBILITY; BIODEGRADABILITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; COLON CARCINOMA; DOSE RESPONSE; DRUG DELIVERY SYSTEM; FIBROSARCOMA; GLIOSARCOMA; NONHUMAN; OSTEOSARCOMA; OVARY CANCER; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; SPINE CANCER; ANIMAL; CHEMISTRY; HUMAN; METABOLISM; NEOPLASMS;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOPOLYMERS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NEOPLASMS; POLYMERS;

EID: 77954249976     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717541003762854     Document Type: Review

References (93)

1. Abe, T., Sakane, M., Ikoma, T., Kobayashi, M., Nakamura, S., Ochiai, N. (2008). Intraosseous delivery of paclitaxel-loaded hydroxyapatite-alginate composite beads delaying paralysis caused by metastatic spine cancer in rats. J Neurosurg Spine. 9:502-510
2. Al-Ghananeem, A.M., Malkawi, A.H., Muammer, Y.M., Balko, J.M., Black, E.P., Mourad, W., Romond, E. (2009). Intratumoral delivery of paclitaxel in solid tumor from biodegradable hyaluronan nanoparticle formulations. AAPS Pharmscitech. 10:410-417
3. Almond, B., Hadba, A., Freeman, S., Cuevas, B., York, A., Detrisac, C., Goldberg, E.P. (2003). Efcacy of mitoxantrone-loaded albumin microspheres for intratumoral chemotherapy of breast cancer. J Contr Rel. 91:147-155
4. Anderson, J.M., Shive, M.S. (1997). Biodegradation and biocom-patibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 28:5-24.
5. Armstrong, D.K., Fleming, G.F., Markman, M., Bailey, H.H. (2006). A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer((R))) in recurrent ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 103:391-396 (Pubitemid 44604492)
6. Athanasiou, K.A., Niederauer, G.G., Agrawal, C.M. (1996). Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid polyglycolic acid copolymers. Biomaterials. 17:93-102.
7. Attenello, F.J., Mukherjee, D., Datoo, G., Mcgirt, M.J., Bohan, E., Weingart, J.D., Olivi, A., Quinones-Hinojosa, A., Brem, H. (2008). Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol. 15:2887-2893
8. Au, J.L.S., Jang, S.H., Zheng, J., Chen, C.T., Song, S., Hu, L., Wientjes, M.G. (2001). Determinants of drug delivery and transport to solid tumors. J Contr Rel. 74:31-46.
9. Azouz, S.M., Walpole, J., Amirifeli, S., Taylor, K.N., Grinstaf, M.W., Colson, Y.L. (2008). Prevention of local tumor growth with paclitaxel-loaded microspheres. J Torac Cardiovasc Surg. 135:1014-1021
10. Berrada, M., Serreqi, A., Dabbarh, F., Owusu, A., Gupta, A., Lehnert, S. (2005). A novel non-toxic camtothecin formulation for cancer chemotherapy. Biomaterials. 26:2115-2120
11. Berrada, M., Yang, Z., Lehnert, S. (2002). Tumor treatment by sustained intratumoral release of 5-fuorouracil: efects of drug alone and in combined treatments. Int J Radiat Oncol Biol Phys. 54:1550-1557
12. Bouhadir, K.H., Alsberg, E., Mooney, D.J. (2001). Hydrogels for combination delivery of antineoplastic agents. Biomaterials. 22:2625-2633
13. Chourasia, M.K., Jain, S.K. (2004). Polysaccharides for colon targeted drug delivery. Drug Deliv. 11:129-148
14. D'Souza, R., Mutalik, S., Udupa, N. (2006). In vitro and in vivo preparation evaluations of bleomycin implants and microspheres prepared with DL-poly(lactide-co-glycolide). Drug Dev Ind Pharm. 32:175-184
15. Davidson, B.S., Izzo, F., Cromeens, D.M., Stephens, L.C., Siddik, Z.H., Curley, S.A. (1995). Collagen matrix cisplatin prevents local tumor growth after margin-positive resection. J Surg Res. 58:618-624
16. De Souza, R., Zahedi, P., Allen, C., Piquette-Miller, M. (2009). Biocompatibility of injectable chitosan-phospholipid implant systems. Biomaterials. 30:3818-3824
17. Desai, K.G., Mallery, S.R., Schwendeman, S.P. (2008). Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with n-acetylcysteine, a MMP inhibitor. Pharm Res. 25:586-597.
18. Dodane, V., Vilivalam, V.D. (1998). Pharmaceutical applications of chitosan. Pharm Sci Technol To. 1:246-253
19. Elstad, N.L., Fowers, K.D. (2009). OncoGel (ReGel/paclitaxel)\clini-cal applications for a novel paclitaxel delivery system. Adv Drug Deliv Rev. 61:785-794
20. Exner, A.A., Saidel, G.M. (2008). Drug-eluting polymer implants in cancer therapy. Expert Opin Drug Deliv. 5:775-788
21. Fraser, J.R.E., Laurent, T.C., Laurent, U.B.G. (1997). Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 242:27-33.
22. Friess, W. (1998). Collagen\biomaterial for drug delivery. Eur J Pharm Biopharm. 45:113-136
23. Fu, K., Pack, D.W., Klibanov, A.M., Langer, R. (2000). Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res. 17:100-106
24. Fulzele, S.V., Satturwar, P.M., Dorle, A.K. (2003). Study of the biodeg-radation and in vivo biocompatibility of novel biomaterials. Eur J Pharm Sci. 20:53-61.
25. Fung, L.K., Saltzman, W.M. (1997). Polymeric implants for cancer chemotherapy. Adv Drug Deliv Rev. 26:209-230
26. Gasparini, G. (2001). Metronomic scheduling: the future of chemotherapy? Lancet Oncol. 2:733-740
27. Gelse, K., Poschl, E., Aigner, T. (2003). Collagens\structure, function, and biosynthesis. Adv Drug Deliv Rev. 55:1531-1546
28. Ghosh, S. (2004). Recent research and development in synthetic polymer-based drug delivery systems. J Chem Res S. 241-246
29. Grant, J., Blicker, M., Piquette-Miller, M., Allen, C. (2005). Hybrid flms from blends of chitosan and egg phosphatidylcholine for localized delivery of paclitaxel. J Pharm Sci. 94:1512-1527
30. Grant, J., Lee, H., Soo, P.L., Cho, J., Piquette-Miller, M., Allen, C. (2008). Infuence of molecular organization and interactions on drug release for an injectable polymer-lipid blend. Int J Pharm. 360:83-90.
31. Grayson, A.C.R., Voskerician, G., Lynn, A., Anderson, J.M., Cima, M.J., Langer, R. (2004). Diferential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo-and co-polymers for a polymeric drug-delivery microchip. J Biomater Sci Polym Ed. 15:1281-1304
32. Han, H.D., Song, C.K., Park, Y.S., Noh, K.H., Kim, J.H., Hwang, T., Kim, T.W., Shin, B.C. (2008). A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor efects by combining with a vaccinia viral vaccine. Int J Pharm. 350:27-34.
33. Hanes, J., Sills, A., Zhao, Z., Suh, K.W., Tyler, B., Dimeco, F., Brat, D., Choti, M., Leong, K., Pardoll, D., Brem, H. (2001). Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors. Pharm Res. 18:899-906.
34. Harper, E., Dang, W.B., Lapidus, R.G., Garver, R.I. (1999). Enhanced efcacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice. Clin Cancer Res. 5:4242-4248
35. Hawe, A., Friess, W. (2007). Formulation development for hydropho-bic therapeutic proteins. Pharm Dev Technol. 12:223-237
36. Hickey, T., Kreutzer, D., Burgess, D.J., Moussy, F. (2002). In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the infammatory tissue response to implantable medical devices. J Biomed Mater Res. 61:180-187
37. Ho, E.A., Lim Soo, P., Allen, C., Piquette-Miller, M. (2006). Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors. J Contr Rel. 117:20-27
38. Ho, E.A., Vassileva, V., Allen, C., Piquette-Miller, M. (2005). In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel. J Contr Rel. 104:181-191
39. Hsu, W., Lesniak, M., Tyler, B., Brem, H. (2005). Local delivery of interleukin-2 and adriamycin is synergistic in the treatment of experimental malignant glioma. J Neuro-Oncol. 74:135-140
40. Jagur-Grodzinski, J. (2009). Polymers for targeted and/or sustained drug delivery. Polym Adv Technol. 20:595-606.
41. Jain, J.P., Chitkara, D., Kumar, N. (2008). Polyanhydrides as localized drug delivery carrier: an update. Expert Opin Drug Del. 5:889-907.
42. Jain, J.P., Modi, S., Domb, A.J., Kumar, N. (2005). Role of polyanhy-drides as localized drug carriers. J Contr Rel. 103:541-563
43. Jang, S.H., Wientjes, M.G., Lu, D., Au, J.L.S. (2003). Drug delivery and transport to solid tumors. Pharm Res. 20:1337-1350
44. Kakinoki, S., Taguchi, T. (2007). Antitumor efect of an injectable in-situ forming drug delivery system composed of a novel tissue adhesive containing doxorubicin hydrochloride. Eur J Pharm Biopharm. 67:676-681
45. Kean, T., Tanou, M. (2010). Biodegradation, biodistribution and tox-icity of chitosan. Adv Drug Deliv Rev. 62:3-11.
46. Kim, S., Kim, J.H., Jeon, O., Kwon, I.C., Park, K. (2009). Engineered polymers for advanced drug delivery. Eur J Pharm Biopharm. 71:420-430
47. Konishi, M., Tabata, Y., Kariya, M., Suzuki, A., Mandai, M., Nanbu, K., Takakura, K., Fujii, S. (2003). In vivo anti-tumor efect through the controlled release of cisplatin from biodegradable gelatin hydrogel. J Contr Rel. 92:301-313
48. Kumar, M.N.V.R. (2000). A review of chitin and chitosan applications. React Funct Polym. 377:76-84.
49. Kumar, N., Langer, R.S., Domb, A.J. (2002). Polyanhydrides: an overview. Adv Drug Deliv Rev. 54:889-910.
50. Lee, J.S., An, T.K., Chae, G.S., Jeong, J.K., Cho, S.H., Lee, H.B., Khang, G. (2005). Evaluation of in vitro and in vivo antitumor activity of BCNU-loaded PLGA wafer against 9L gliosarcoma. Eur J Pharm Biopharm. 59:169-175
51. Lee, S.H., Shin, H. (2007). Matrices and scafolds for delivery of bioac-tive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev. 59:339-359
52. Liao, Y.H., Jones, S.A., Forbes, B., Martin, G.P., Brown, M.B. (2005). Hyaluronan: pharmaceutical characterization and drug delivery. Drug Deliv. 12:327-342
53. Liu, Z.H., Jiao, Y.P., Wang, Y.F., Zhou, C.R., Zhang, Z.Y. (2008). Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev. 60:1650-1662
54. Ma, X., Yu, H. (2006). Global burden of cancer. Yale J Biol Med. 79:85-94.
55. Maeda, Y., Kimura, Y. (2004). Antitumor efects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice. J Nutr. 134:945-950
56. Malafaya, P.B., Silva, G.A., Reis, R.L. (2007). Natural-origin polymers as carriers and scafolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Deliv Rev. 59:207-233
57. Mendez, C.M., Mcclain, C.J., Marsano, L.S. (2005). Albumin therapy in clinical practice. Nutr Clin Pract. 20:314-320
58. Minchinton, A.I., Tannock, I.F. (2006). Drug penetration in solid tumours. Nat Rev Cancer. 6:583-592
59. Mourya, V.K., Inamdar, N.N. (2008). Chitosan-modifcations and applications: opportunities galore. React Funct Polym. 68:1013-1051
60. Muzzarelli, R.A.A. (1993). Biochemical signifcance of exogenous chitins and chitosans in animals and patients. Carbohydr Polym. 20:7-16.
61. Nair, L.S., Laurencin, C.T. (2007). Biodegradable polymers as bioma-terials. Prog Polym Sci. 32:762-798
62. Nezhadi, S.H., Choong, P.F.M., Lotfpour, F., Dass, C.R. (2009). Gelatin-based delivery systems for cancer gene therapy. J Drug Target. 17:731-738
63. Obara, K., Ishiharab, M., Ozekia, Y., Ishizukaa, T., Hayashib, T., Nakamuraa, S., Saitod, Y., Yurad, T., Matsuib, T., Hattorib, H., Takaseb, B., Ishiharac, M., Kikuchib, M., Maeharaa, T. (2005). Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent efect on subcutaneous tumor growth in mice. J Contr Rel. 110:79-89.
64. Olsen, D., Yang, C., Bodo, M., Chang, R., Leigh, S., Baez, J., Carmichael, D., Perala, M., Hamalainen, E., Jarvinen, M., Polarek, J. (2003). Recombinant collagen and gelatin for drug delivery. Adv Drug Deliv Rev. 55:1547-1567
65. Park, H., Park, K. (1996). Biocompatibility issues of implantable drug delivery systems. Pharm Res. 13:1770-1776
66. Patil, G.V. (2003). Biopolymer albumin for diagnosis and in drug delivery. Drug Dev Res. 58:219-247
67. Pillai, O., Panchagnula, R. (2001). Polymers in drug delivery. Curr Opin Chem Biol. 5:447-451
68. Qin, C.Q., Du, Y.M., Xiao, L., Li, Z., Gao, X.H. (2002). Enzymic preparation of water-soluble chitosan and their antitumor activity. Int J Biol Macromol. 31:111-117
69. Ranganath, S.H., Wang, C. (2008). Biodegradable microfber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma. Biomaterials. 29:2996-3003.
70. Read, T.A., Farhadi, M., Bjerkvig, R., Olsen, B.R., Rokstad, A.M., Huszthy, P.C., Vajkoczy, P. (2001). Intravital microscopy reveals novel antivascular and antitumor efects of endostatin delivered locally by alginate-encapsulated cells. Cancer Res. 61:6830-6837
71. Rhines, L.D., Sampath, P., Dimeco, F., Lawson, H.C., Tyler, B., Hanes, J., Olivi, A., Brem, H. (2002). Local immunotherapy with inter-leukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma. Neurosurgery. 52:872-880
72. Rihova, B. (1996). Biocompatibility of biomaterials: hemocompat-ibility, immunocompatibility and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers. Adv Drug Deliv Rev. 21:157-176
73. Ruel-Gariepy, E., Shive, M., Bichara, A., Berrada, M., Le Garrec, D., Chenite, A., Leroux, J.C. (2004). A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur J Pharm Biopharm. 57:53-63.
74. Rugo, H.S. (2008). New treatments for metastatic breast cancer: mechanisms of action of nanoparticle albumin-bound taxanes. Community Oncol. 5:8-12.
75. Sawyer, A.J., Piepmeier, J.M., Saltzman, W.M. (2006). New methods for direct delivery of chemotherapy for treating brain tumors. Yale J Biol Med. 79:141-152
76. Scharovsky, O.G., Mainetti, L.E., Rozados, V.R. (2009). Metronomic chemotherapy: changing the paradigm that more is better. Curr Oncol. 16:91-99.
77. Shikani, A.H., Domb, A.J. (2000). Polymer chemotherapy for head and neck cancer. Te Laryngoscope. 110:907-917
78. Shilpa, A., Agrawal, S.S., Ray, A.R. (2003). Controlled delivery of drugs from alginate matrix. J Macromol Sci-Pol R. 43:187-221.
79. Sinha, V.R., Kumria, R. (2001). Polysaccharides in colon-specifc drug delivery. Int J Pharm. 224:19-38.
80. Storm, P.B., Moriarity, J.L., Tyler, B., Burger, P.C., Brem, H., Weingart, J. (2002). Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efcacy. J Neuro-Oncol. 56:209-217
81. Stuart, K., Stokes, K., Jenkins, R., Trey, C., Clouse, M. (1993). Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization. Cancer. 72:3202-3209
82. Ta, H.T., Dass, C.R., Larson, I., Choong, P.F.M., Dunstan, D.E. (2009). A chitosan-dipotassium orthophosphate hydrogel for the delivery of doxorubicin in the treatment of osteosarcoma. Biomaterials. 30:3605-3613
83. Taylor, M.S., Daniels, A.U., Andriano, K.P., Heller, J. (1994). 6 Bioabsorbable polymers\in-vitro acute toxicity of accumulated degradation products. J Appl Biomater. 5:151-157
84. Tonnesen, H.H., Karlsen, J. (2002). Alginate in drug delivery systems. Drug Dev Ind Pharm. 28:621-630
85. Vassileva, V., Grant, J., De Souza, R., Allen, C., Piquette-Miller, M. (2007). Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efcacy of paclitaxel in a human ovarian cancer xenograft model. Cancer Chemother Pharmacol. 60:907-914
86. Wallace, D.G., Rosenblatt, J. (2003). Collagen gel systems for sustained delivery and tissue engineering. Adv Drug Deliv Rev. 55:1631-1649
87. Wang, P.P., Frazier, J., Brem, H. (2002). Local drug delivery to the brain. Adv Drug Deliv Rev. 54:987-1013.
88. Weinberg, B.D., Ai, H., Blanco, E., Anderson, J.M., Gao, J.M. (2007). Antitumor efcacy and local distribution of doxorubicin via intratumoral delivery from polymer millirods. J Biomed Mater Res Part A. 81A:161-170
89. Westphal, M., Hilt, D.C., Bortey, E., Delavault, P., Olivares, R., Warnke, P.C., Whittle, I.R., Jaaskelainen, J., Ram, Z. (2003). A phase 3 trial of local chemotherapy with biodegradable carmus-tine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-Oncology. 5:79-88.
90. Yadav, A.K., Mishra, P., Agrawal, G.P. (2008). An insight on hyaluronic acid in drug targeting and drug delivery. J Drug Target. 16:91-107.
91. Ye, S.-F., Hou, Z.-Q., Zhou, Z.-M., Zhong, L.-M., Zhang, Q.-Q. (2008). Intratumoral chemotherapy with an implantable collagen flm impregnated with epirubicin-loaded polylactic acid micro-spheres inhibits tumor growth in hepatocellular carcinoma xenografts. Chin J Biochem Eng. 27:590-596
92. Zahedi, P., De Souza, R., Piquette-Miller, M., Allen, C. (2009). Chitosan-phospholipid blend for sustained and localized delivery of docetaxel to the peritoneal cavity. Int J Pharm.
93. Zheng, J.P., Wang, C.Z., Wang, X.X., Wang, H.Y., Zhuang, H., De Yao, K. (2007). Preparation of biornimetic three-dimensional gelatin/montmorillonite- chitosan scafold for tissue engineering. React Funct Polym. 67:780-788